Stefan A. Dyckerhoff Sells 7,814 Shares of Astera Labs, Inc. (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff sold 7,814 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $107.17, for a total value of $837,426.38. Following the sale, the director now owns 121,803 shares of the company’s stock, valued at $13,053,627.51. The trade was a 6.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Astera Labs Stock Down 5.6 %

NASDAQ ALAB opened at $99.60 on Thursday. The firm’s 50-day moving average is $73.12 and its two-hundred day moving average is $60.57. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $113.85.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. The firm’s revenue for the quarter was up 47.1% compared to the same quarter last year. On average, equities analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in ALAB. Avior Wealth Management LLC purchased a new position in Astera Labs in the 3rd quarter valued at approximately $361,000. Sei Investments Co. acquired a new position in Astera Labs during the 1st quarter worth $952,000. Meeder Asset Management Inc. purchased a new stake in Astera Labs during the 3rd quarter worth about $1,141,000. Bank of Hawaii acquired a new stake in Astera Labs in the 3rd quarter valued at about $1,409,000. Finally, Vanguard Group Inc. acquired a new position in shares of Astera Labs during the first quarter worth about $127,268,000.

Analyst Ratings Changes

ALAB has been the subject of a number of research reports. Citigroup began coverage on shares of Astera Labs in a report on Monday, November 18th. They set a “buy” rating and a $120.00 target price for the company. Barclays increased their price objective on shares of Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Needham & Company LLC restated a “buy” rating and set a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. Morgan Stanley increased their price target on Astera Labs from $74.00 to $94.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, Astera Labs presently has a consensus rating of “Buy” and an average target price of $94.67.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.